A Dark Vector Cognition product

Item 6. Exhibits

3K characters. Original on sec.gov ·

Item 6. Exhibits

| --- | --- |

Exhibit No.Incorporated by Reference
Exhibit DescriptionFormFile No.ExhibitFiling DateFiled By
10.15*Oracle Corporation Amended and Restated 2020 Equity Incentive Plan (as approved by the stockholders on November 10, 2021)8-K001-3599210.1611/12/21Oracle Corporation
31.01‡Rule 13a-14(a)/15d-14(a) Certification of Principal Executive and Financial Officer
32.01†Section 1350 Certification of Principal Executive and Financial Officer
101‡Interactive Data Files Pursuant to Rule 405 of Regulation S-T, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets as of November 30, 2021 and May 31, 2021, (ii) Condensed Consolidated Statements of Operations for the three and six months ended November 30, 2021 and 2020, (iii) Condensed Consolidated Statements of Comprehensive (Loss) Income for the three and six months ended November 30, 2021 and 2020, (iv) Condensed Consolidated Statements of Stockholders’ (Deficit) Equity for the three and six months ended November 30, 2021 and 2020, (v) Condensed Consolidated Statements of Cash Flows for the six months ended November 30, 2021 and 2020 and (vi) Notes to Condensed Consolidated Financial Statements
104‡The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended November 30, 2021, formatted in Inline XBRL
*Indicates management contract or compensatory plan or arrangement.
‡Filed herewith.
†Furnished herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, Oracle Corporation has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ORACLE CORPORATION
Date: December 10, 2021By:/s/ Safra A. Catz
Safra A. Catz Chief Executive Officer and Director (Principal Executive and Financial Officer)
Date: December 10, 2021By:/s/ William Corey West
William Corey West
Executive Vice President, Chief Accounting Officer (Principal Accounting Officer)

Previous: Item 1A. Risk Factors